Achieve Life Sciences enters agreement with Jefferies for up to $150 million at-the-market stock offering

• Achieve Life Sciences entered an at-the-market equity distribution agreement with Jefferies for up to USD 150 million of common stock.
• Jefferies will act as sales agent, using commercially reasonable efforts, with a commission of up to 3% of gross proceeds.
• Proceeds targeted for cytisinicline commercialization, funding a Phase 3 e-cigarette cessation trial, working capital, general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-352229), on August 14, 2026, and is solely responsible for the information contained therein.